Yin et al. have found that tumor suppressor genes, such as BRCA1, BRCA2 and MLH1, involved in the modulating the drug resistance in ovarian cancer via regulating DNA damage-related and apoptosis related signaling pathways60. Here, BRCA2 is linked to ovarian carcinoma.